QualityDipStocks / Finance · Life Insurance
Aegon York Registry Shares AEG
Outside our quality screen, so we don’t track its dips. It’s 14% below its 52-week high.
Outside our quality screen. No fair value estimate for now: its share count is unclear.
- Fair value est.
- n/a
- Market Value
- —
- Off 52-wk high
- −14%
- Risk vs market
- Below marketbeta 0.87
2 bullish · 2 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
No estimate for AEG: SEC share count doesn't match the listed shares (share class / ADR ratio unclear). We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much AEG moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves a bit less than the market, and its own price swings are 1.9× the S&P 500’s.
- Beta vs S&P 500
- 0.87
- Volatility
- 24% vs 13% SPY
- Correlation SPY
- 0.46
- Correlation QQQ
- 0.33
Valuation details
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 2 of 5
Cash returnsDividend yield of 4.5% ($667M paid over 12 months, 61% of earnings).
ValuationPrice / book of 1.4×, below the 1.7× median for the 296 Finance companies we cover.
Top bearish points 2 of 5
ProfitabilityReturn on equity of 11%, below the 12% median for the 291 Finance companies we cover.
QualityDoesn’t pass our quality screen: no positive free cash flow; ROE under 12% and ROIC under 10%; sales down vs the year-ago quarter.
All fundamentals
P/E 13.5 · ROE 11%
Valuation
- P/E
- 13.5×Finance median 13.6×
- Price / FCF
- n/acash flow isn't a clean measure for an insurer
- FCF yield
- n/acash flow isn't a clean measure for an insurer
- EV / EBITDA
- n/anot meaningful for an insurer
- Price / sales
- n/anot reported in its SEC filings
- Price / book
- 1.40×
- Market cap
- $14.8Blisted
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- n/anot reported in its SEC filings
- Sales growth, 12 months
- n/ano year-ago 12-month revenue
- Sales growth, 3 yrs
- n/anot reported in its SEC filings
- Diluted EPS, 12 months
- n/anot reported in its SEC filings
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- $1.1B
- Net income growth
- +42%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for an insurer
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- n/anot reported in its SEC filings
- FCF margin
- n/anot reported in its SEC filings
- Return on equity
- 11%
- Return on invested capital
- n/anot meaningful for an insurer
Balance sheet
- Cash & short-term inv.
- $3.1B
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/anot meaningful for an insurer
- Debt / equity
- n/adeposits/float make debt/equity not comparable for an insurer
- Interest coverage
- n/anot meaningful for an insurer
Cash flow & returns
- Free cash flow, 12 months
- $440M
- FCF growth, 12 months
- −45%
- Dividend yield
- 4.51%$667M paid
- Payout ratio
- 61%
- Buybacks, 12 months
- $615M4.2% of market cap
- Share count, 1 year
- n/ano quarterly diluted share count
- Stock-based comp
- n/anot reported in its SEC filings
Trailing 12 months to Dec 31, 2025; balance sheet at Dec 31, 2025. From Aegon York Registry Shares’s SEC filings, reported in EUR and converted to US dollars. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $-4.3B · Sales −8%
- Free cash flow, 12 months−$4.3B
- Free-cash-flow yield−29.1%
- Return on equity11%
- Sales growth (latest quarter vs year-ago quarter)−8%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $8.22
- 52-wk lowlowest close, 1 year$6.79−17.4%
- PriceMon Nov 2 close$8.22you are here
- 52-wk highhighest close, 1 year$9.53+15.9%
Momentum & 52-week range
RSI 41 · 5 days +0.9%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
AEG is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Aegon York Registry Shares in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Life Insurance
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.